Description
Amisulpride Tablets (50 mg / 100 mg / 200 mg / 400 mg)
Healthy Inc is a specialized global supplier and exporter of advanced CNS, psychiatry, and targeted neurological therapeutics. We provide ultra-high-purity, kinetically optimized Amisulpride Tablets, manufactured in WHO–GMP certified, high-precision specialized CNS facilities. This “Second-Generation Atypical Antipsychotic” is a massive-volume strategic export to mental health hospitals, neurology clinics, and government health ministries, serving as a globally preferred intervention for Schizophrenia and Dysthymia (Chronic Depression).
Product Overview
This formulation operates as a “Limbic-Specific Regulator.” Amisulpride is highly unique due to its dose-dependent biphasic effect, allowing it to treat a wider spectrum of psychiatric symptoms than traditional neuroleptics.
Mechanism 1 (Presynaptic Blockade – Low Dose): At low doses (e.g., 50–100 mg), Amisulpride preferentially blocks presynaptic $D_2$ / $D_3$ autoreceptors. This actually increases dopamine transmission in specific pathways, physically relieving “negative symptoms” like lack of motivation, social withdrawal, and flat affect.
Mechanism 2 (Postsynaptic Blockade – High Dose): At higher doses (e.g., 400–800 mg), it blocks postsynaptic $D_2$ / $D_3$ receptors in the limbic system. This “muffles” the dopamine overactivity responsible for “positive symptoms” such as delusions and hallucinations.
Mechanism 3 (Limbic Selectivity): Unlike older drugs, Amisulpride has a very low affinity for receptors in the striatum. This results in a significantly lower risk of Extrapyramidal Symptoms (EPS) like tremors or muscle stiffness, and virtually no weight gain or sedative effect.
Product Composition & Strength
We supply this product in a full range of strengths to facilitate both low-dose “Disthymia” protocols and high-dose “Schizophrenia” maintenance.
| Active Ingredient | Strength | Primary Clinical Function |
| Amisulpride USP/BP | 50 mg / 100 mg | The Negative Symptom Unit: Used to treat social withdrawal, depression, and lack of initiative. |
| Amisulpride USP/BP | 200 mg | The Transition Anchor: Used for moderate psychosis or as a step-up dose during titration. |
| Amisulpride USP/BP | 400 mg | The Positive Symptom Payload: High-potency dose for acute psychotic episodes and hallucinations. |
Technical & Logistics Specifications
HS Code: 3004.90.79 (Other medicaments acting on the CNS – Antipsychotics)
CAS Number: 71675-85-9 (Amisulpride)
Dosage Form: Uncoated or Film-Coated Tablet (Scored for dosing flexibility)
Packaging: Alu-Alu or Alu-PVC Blisters. Protects the API from environmental humidity; our moisture-lock packaging ensures 24-month stability in Zone IVb tropical climates.
Manufacturing Authority & Compliance
Receptor Affinity Precision: Our manufacturing process focuses on absolute chemical purity to ensure the $D_2$/$D_3$ selectivity remains exact, providing the predictable clinical response required for complex psychiatric cases.
Neuro-Grade Containment: We utilize Segregated CNS Production Blocks to ensure zero cross-contamination, meeting the strictest international regulatory standards for antipsychotic medications.
Primary Indications
Psychiatry: Acute and chronic Schizophrenia characterized by positive symptoms (delusions, hallucinations) and/or negative symptoms (blunted affect, social withdrawal).
Neurology: Management of Dysthymia (Chronic Low-Grade Depression).
Geriatrics: Management of psychosis in elderly patients (due to its low sedative and cardiovascular side-effect profile).
Dosage & Administration
Negative Symptoms: Typically 50 mg to 300 mg once daily.
Positive Symptoms: 400 mg to 800 mg per day, usually in two divided doses.
Administration: Can be taken with or without food.
Safety Warning: Hyperprolactinemia. Amisulpride can increase prolactin levels; monitor for symptoms like galactorrhea or menstrual irregularities. Monitor for QT Prolongation in patients with pre-existing cardiac conditions. Strictly contraindicated in patients with Pheochromocytoma or prolactin-dependent tumors.
Global Export & Contract Manufacturing
Healthy Inc is a premier CNS Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for next-generation Antipsychotics. Whether you are a Mental Health Hospital Network in Africa or a B2B Pharma Marketplace partner in the CIS, we ensure secure, WHO-GMP compliant delivery.
Reviews
There are no reviews yet.